Cart
sales@molnova.com
Sodium Nitroprusside Dihydrate
CAS No. 13755-38-9
Sodium Nitroprusside Dihydrate( Sodium nitroprusside dihydrate | Sodium Nitroferricyanide(III) Dihydrate )
Catalog No. M17986 CAS No. 13755-38-9
Sodium Nitroprusside Dihydrate is a potent vasodilator working through releasing NO spontaneously in blood.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 41 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSodium Nitroprusside Dihydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionSodium Nitroprusside Dihydrate is a potent vasodilator working through releasing NO spontaneously in blood.
-
DescriptionSodium Nitroprusside Dihydrate is a potent vasodilator working through releasing NO spontaneously in blood.(In Vitro):Nitroprusside disodium dehydrate sensitizes human gastric cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
-
In VitroNitroprusside disodium dehydrate sensitizes human gastric cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
-
In Vivo——
-
SynonymsSodium nitroprusside dihydrate | Sodium Nitroferricyanide(III) Dihydrate
-
PathwayAngiogenesis
-
TargetEGFR
-
Recptorguanylate cyclase
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number13755-38-9
-
Formula Weight297.95
-
Molecular FormulaC5H4FeN6Na2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 46 mg/mL; 154.39 mM
-
SMILES[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.O.O.[Na+].[Na+].[Fe+4]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
EGF816 mesylate
EGF816 (Nazartinib) is a potent, irreversible, mutant-selective EGFR inhibitor with Ki and Kinact of 31 nM and 0.222 min-1, respectively.
-
ZD-4190
ZD-4190 is a inhibitor of the vascular endothelial cell growth factor receptor 2 (VEGFR2) and of epidermal growth factor receptor (EGFR) signalling used for the treatment of cancer.
-
PD158780
PD 158780 reversibly inhibits auto and transphosphorylation of all four members of the ErbB receptor superfamily: EGFR ErbB2 ErbB3 and ErbB4 (IC50s: 8μM 49 nM 52 nM and 52 nM in cell assay).
